找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends; Mark A. Giembycz,Brian J. O’Connor Book 2000 Springer Basel AG 2000 Atm

[復制鏈接]
樓主: 決絕
31#
發(fā)表于 2025-3-26 22:04:06 | 只看該作者
,Grenzf?lle der Functionen ?, and ?,,a high level of reliability and accuracy, be safe, acceptable to the patient, easy to perform and non-invasive. The latter demands that the technique should not break the skin or the lining epithelium and should be devoid of effects on the tissues of the body by the dissipation of energy or the intr
32#
發(fā)表于 2025-3-27 04:57:24 | 只看該作者
https://doi.org/10.1007/978-3-662-25776-0s obtained through controlled clinical trials in patients of a similar age and disease severity as the group in which the drug is being considered for use. Abundant, high quality clinical efficacy and safety data have been obtained on the use of inhaled corticosteroids in children >3 years of age wi
33#
發(fā)表于 2025-3-27 09:14:10 | 只看該作者
Wilhelm Magnus,Fritz Oberhettingerrted the benefits of oral cortisone on ragweed pollen-induced hay fever and asthma. This was followed by a report by Gelfand [2], demonstrating clinical benefit from inhaled cortisone in a small group of patients with both allergic or non-allergic asthma. Subsequently, a multicenter trial run by the
34#
發(fā)表于 2025-3-27 12:10:55 | 只看該作者
35#
發(fā)表于 2025-3-27 15:00:16 | 只看該作者
36#
發(fā)表于 2025-3-27 19:24:51 | 只看該作者
37#
發(fā)表于 2025-3-28 00:11:27 | 只看該作者
978-3-0348-9585-9Springer Basel AG 2000
38#
發(fā)表于 2025-3-28 03:37:37 | 只看該作者
39#
發(fā)表于 2025-3-28 07:46:26 | 只看該作者
40#
發(fā)表于 2025-3-28 14:12:21 | 只看該作者
,Is Chronic Use of β2-Agonists Detrimental in the Treatment of Asthma?,enging the wisdom of regular use of the short-acting β.-agonists which traditionally have formed the mainstay of treatment for bronchial asthma [1–5]. Although all national and international guidelines for the management of asthma now rec-ommend anti-inflammatory therapy for most patients with chron
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2026-1-23 13:15
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
微山县| 新龙县| 朝阳市| 太谷县| 阿拉善左旗| 汤原县| 海口市| 登封市| 彰武县| 尖扎县| 苏尼特左旗| 邮箱| 晋宁县| 株洲市| 福建省| 南投市| 曲靖市| 山阴县| 夹江县| 上虞市| 大连市| 察隅县| 方正县| 习水县| 万山特区| 安乡县| 九寨沟县| 泗阳县| 吉隆县| 延寿县| 东阿县| 剑阁县| 广灵县| 黄冈市| 专栏| 德安县| 峨山| 新丰县| 周口市| 仪征市| 安阳县|